SMS Pharmaceuticals Limited — Others, 14-02-2025: Copy of Newspaper Publication

SMS Pharmaceuticals has announced a board meeting to discuss the financial results for the third quarter and nine months ended 31st December 2024. The unaudited standalone and consolidated results will be made available in major newspapers and on the company’s website.

This update signals continued transparency and the company’s commitment to keeping shareholders informed. Positive investor sentiment may arise from the regular updates on financial performance, reflecting ongoing operational stability. Investors should watch for potential growth indicators in the results and assess any strategic changes that could impact future performance.